Statistics
Publications
2
Citations
46
H-Index
2
Active since
1989
Affiliations
Bristol-Myers Squibb (Germany)(Current)
Saul W. Fink is an author at Bristol-Myers Squibb (Germany) specializing in analytical chemistry, drug development, and engineering.
Publications per year
1989–2000
2
2
DEVELOPMENT OF REVERSED-PHASE CHIRAL HPLC METHODS USING MASS SPECTROMETRY COMPATIBLE MOBILE PHASES
Kumar V. Penmetsa, Christopher D. Reddick, Saul W. Fink et al. · Journal of Liquid Chromatography & Related Technologies · 2000 · 31 citations
Pharmaceutical Science, Engineering, Biological Mass Spectrometry +25
1–2 of 2